RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

David E.I. Pyott

A collection of news and information related to David E.I. Pyott published by this site and its partners.

Top David E.I. Pyott Articles see all

Displaying items 1-5
  • Allergan to slash workforce by 1,500

    Allergan to slash workforce by 1,500
    Botox maker Allergan Inc. said Monday that it will cut 1,500 employees, most of them in Southern California, in a cost-cutting effort the Irvine company hopes will help it fight off a hostile takeover bid by a Canadian rival.
  • Allergan employees have mixed emotions as layoffs loom

    Allergan employees have mixed emotions as layoffs loom
    Feelings were mixed among Allergan Inc. employees one day after the Botox maker announced 1,500 job cuts, mostly in Southern California. Outside of Allergan’s Irvine campus, where the bulk of the 650 research and development jobs the company...

    Most of Allergan's 1,500 job cuts will be in Southern California

    Most of Allergan's 1,500 job cuts will be in Southern California
    Most of the 1,500 job cuts that Botox maker Allergan Inc. announced Monday morning will be made in Southern California, the company’s chief executive said. Allergan plans to eliminate 650 research and development jobs, the bulk of them at its...

    Allergan employees, Irvine officials worried over Valeant offer

    Allergan employees, Irvine officials worried over Valeant offer
    Wall Street sharks are not the only ones keeping a close watch on the contentious battle for control of Allergan Inc., the Irvine company that makes Botox. So are thousands of the company's scientists and researchers, many of whose jobs may be at risk....

    Allergan urges shareholders to reject Valeant offer

    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...